Gilead Cornered Into Expanding Access To HIV, Hep C Drugs in Malaysia, Other Countries

Faced with the prospect of a compulsory license in Malaysia, Gilead has reviewed its generic licensing agreements to grant access to low-cost versions of its HIV and hepatitis C drugs in the country and three other middle-income nations.